DCM
PCVX icon

Driehaus Capital Management’s Vaxcyte PCVX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.39M Sell
73,376
-987,487
-93% -$32.1M 0.02% 325
2025
Q1
$40.1M Sell
1,060,863
-105,970
-9% -$4M 0.39% 78
2024
Q4
$95.5M Sell
1,166,833
-554,463
-32% -$45.4M 0.79% 24
2024
Q3
$197M Sell
1,721,296
-213,451
-11% -$24.4M 1.69% 5
2024
Q2
$146M Buy
1,934,747
+66,940
+4% +$5.05M 1.41% 9
2024
Q1
$128M Buy
1,867,807
+193,439
+12% +$13.2M 1.27% 12
2023
Q4
$105M Buy
1,674,368
+350,484
+26% +$22M 1.27% 9
2023
Q3
$67.5M Buy
1,323,884
+134,027
+11% +$6.83M 0.88% 22
2023
Q2
$59.4M Buy
1,189,857
+575,951
+94% +$28.8M 0.75% 26
2023
Q1
$23M Sell
613,906
-216,889
-26% -$8.13M 0.32% 99
2022
Q4
$39.8M Buy
830,795
+247,189
+42% +$11.9M 0.59% 42
2022
Q3
$14M Buy
583,606
+35,416
+6% +$850K 0.21% 146
2022
Q2
$11.9M Buy
548,190
+458,190
+509% +$9.97M 0.19% 173
2022
Q1
$2.17M Buy
+90,000
New +$2.17M 0.03% 318